Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs.

Source:http://linkedlifedata.com/resource/pubmed/id/9448591

Download in:

View as

General Info

PMID
9448591